Contract HHSD200201792524I
Rafa Laboratories Ltd · Department Of Health And Human Services · December 22, 2016
Rafa Laboratories Ltd was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on December 22, 2016 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 3 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on October 1, 2018. If all options are exercised, the contract could reach $149.99 million.
Contract details
- PIID
- HHSD200201792524I
- Award type
- —
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- December 22, 2016
- Latest action
- October 1, 2018
Description
ATROPINE SULFATE AUTO-INJECTOR, TRAINING DEVICE, TRAINING - MASTER IDIQ
Modification timeline
-
October 1, 2018Mod 3$0
-
September 12, 2018Mod 2$-10.0K
-
August 23, 2018Mod 1$0
-
December 22, 2016Base award$10.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 27, 2026 | $92.33M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSD200201792524I?
Contract HHSD200201792524I is a federal contract awarded to Rafa Laboratories Ltd by Department Of Health And Human Services on December 22, 2016 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 3 times since the base award.
Who won contract HHSD200201792524I?
Rafa Laboratories Ltd won contract HHSD200201792524I from Department Of Health And Human Services.
How much is contract HHSD200201792524I worth?
Contract HHSD200201792524I has obligated $0 to date but carries a potential ceiling of $149.99 million if fully funded and all options are exercised.